Apple Health (Medicaid) Provider Alert
Attention providers
What changed? The Health Care Authority (HCA) has updated its COVID-19 therapies policy with information regarding new COVID-19 monoclonal antibodies.
New COVID-19 monoclonal antibodies Retroactive for dates of service on and after February 11, 2022, providers may bill HCA for the following monoclonal antibody treatments:
HCPC code |
Short Description |
Q0222 |
Bebtelovimab 175 mg |
M0222 |
Bebtelovimab injection |
M0223 |
Bebtelovimab injection home |
See Therapies for COVID-19 for more information regarding the policy and procedure codes involved.
COVID-19 Fee Schedule HCA revised the COVID-19 Fee Schedule. See HCA’s Provider billing guides and fee schedules, under COVID-19.
|